Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

Voir toute la documentation

N0290

Sigma-Aldrich

Nitazoxanide

≥98% (HPLC)

Synonyme(s) :

NTZ; 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

10 MG
80,60 €
50 MG
299,00 €

80,60 €

Check Cart for Availability
Devis pour commande en gros
Toutes les photos(1)

Sélectionner une taille de conditionnement

Changer de vue
10 MG
80,60 €
50 MG
299,00 €

About This Item

Formule empirique (notation de Hill) :
C12H9N3O5S
Numéro CAS:
55981-09-4
Poids moléculaire :
307.28
Numéro CE :
259-931-8
Numéro MDL:
MFCD00416599
Code UNSPSC :
12352200
ID de substance PubChem :
329818424
Nomenclature NACRES :
NA.77

80,60 €

Check Cart for Availability
Devis pour commande en gros

Essai

≥98% (HPLC)

Forme

powder

Auteur

Romark

Température de stockage

2-8°C

Chaîne SMILES 

CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+]([O-])=O

InChI

1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)

Clé InChI

YQNQNVDNTFHQSW-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Nitazoxanide (NTZ), a thiazolide compound[1] is a antiparasitic drug with structure similar to niclosamide.[2]

Application

Nitazoxanide has been used:
  • to test its anti-viral activity against chikungunya virus[3]
  • as an antiprotozoal agent to test its effect on cell viability in various cancer cell lines[4]
  • to test its effect on human cytomegalovirus (HCMV) infected human fibroblast HFF cells[5]

Actions biochimiques/physiologiques

Nitazoxanide (NTZ) promotes autophagy by acting on kinase based signaling pathways[5] and acts on mammalian target of rapamycin complex 1 (mTORC1) in Mycobacteria.[2] It has anti-viral property and effectively halts entry and release of chikungunya virus in in vitro studies.[3] NTZ also inhibits Japanese encephalitis virus (JEV) infection in early stages and has the potential to treat other viral infections including dengue, hepatitis B (HBV), coronavirus and human immunodeficiency virus (HIV).[3] It has antineoplastic functionality and may induce apoptosis by promoting proto-oncogene c-Myc inhibition resulting in tumor suppression.[1]
Nitazoxanide is an inhibitor of pyruvate-ferredoxin oxidoreductase (PFOR); Antimicrobial recently found to kill both non-replicating and replicating mycobacteria.
Nitazoxanide is an inhibitor of pyruvate-ferredoxin oxidoreductase (PFOR); FDA approved anti-parasitic drug (2002). Recent work (C & EN Sept. 14, 2009, p. 28) highlights that NTZ kills non-replicating and replicating TB bacteria and no apparent resistance is detected.

Caractéristiques et avantages

This compound was developed by Romark. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
0000296365
0000296365
0000160660
0000114613

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Drug repurposing approach identifies inhibitors of the prototypic viral transcription factor IE2 that block human cytomegalovirus replication
Mercorelli B, et al.
Cell Chemical Biology, 23(3), 340-351 (2016)
Andrew Hemphill et al.
Expert opinion on pharmacotherapy, 7(7), 953-964 (2006-04-26)
Colonisation of the gastrointestinal tract by anaerobic bacteria, protozoa, trematodes, cestodes and/or nematodes and other infectious pathogens, including viruses, represents a major cause of morbidity and mortality in Africa, South America and southeast Asia, as well as other parts of
Cirle A Warren et al.
Antimicrobial agents and chemotherapy, 56(8), 4103-4111 (2012-05-16)
Clostridium difficile infection (CDI) is a serious diarrheal disease that often develops following prior antibiotic usage. One of the major problems with current therapies (oral vancomycin and metronidazole) is the high rate of recurrence. Nitazoxanide (NTZ), an inhibitor of pyruvate:ferredoxin
G Esmat et al.
Liver international : official journal of the International Association for the Study of the Liver, 32 Suppl 1, 146-150 (2012-01-11)
Hepatitis C virus genotype 4 (HCV-4) is the most common type of hepatitis C virus (HCV) in the Middle East and Africa, in particular Egypt. Since the development of new protease inhibitors, the response of HCV-4 to the standard regimen
Benjamin Speich et al.
PLoS neglected tropical diseases, 6(6), e1685-e1685 (2012-06-09)
The currently used anthelmintic drugs, in single oral application, have low efficacy against Trichuris trichiura infection, and hence novel anthelmintic drugs are needed. Nitazoxanide has been suggested as potential drug candidate. The efficacy and safety of a single oral dose
Afficher tous les articles scientifiques apparentés

Articles

Bioactive Molecules for Immunology Research

Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.

Questions

Évaluations

Aucune valeur de notation

Filtres actifs

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique